Valuation Zai Lab Limited Hong Kong S.E.

Stocks

Market Closed - Hong Kong S.E. Other stock markets 11:08:37 17/06/2026 +03			5-day change	1st Jan Change
13.56 ^HKD	-2.87%		+2.26%	-0.66%

06-16	Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug	MT
06-10	Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	1,992	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	1.54%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	1,549	1,605	1,778
Change	-	-58.33%	-2.13%	10.47%	-33.34%	10.91%	3.61%	10.76%
P/E	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-8.01x	-9.51x	-13.2x
PBR	4.35x	-	3.34x	3.36x	2.73x	3.73x	4.01x	3.97x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.2x	0.6x	0.5x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	4.44x	3.34x	2.64x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	3.45x	2.69x	2.35x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-6.37x	-10x	-26.7x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-5.99x	-9.24x	-20.7x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-8.81x	-13.9x	-25.3x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-11.4%	-7.22%	-3.95%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.215	-1.865	-1.347
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	448.7	595.6	755.9
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-243	-159.9	-66.57
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-258.7	-173.7	-85.83
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-240.9	-156.5	-125.8
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-443.1	-387.2	-214.4
Reference price ²	62.85	30.70	27.33	26.19	17.64	17.73	17.73	17.73
Nbr of stocks (in thousands)	96,409	95,972	98,349	108,937	111,219	112,355	-	-
Announcement Date	3/1/22 A	3/1/23 A	2/27/24 A	2/27/25 A	2/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	15.92x	3.44x	9.28x	0.64%	62.54B
UCB	26.98x	5.45x	15.6x	0.59%	55.22B
SAMSUNG BIOLOGICS CO.,LTD.	32.95x	11.15x	21.03x	-.--%	40.9B
CSL LIMITED	-48.34x	2.92x	8.61x	3.79%	35.99B
BIOGEN INC.	31.58x	3.43x	10.37x	-.--%	28.88B
MODERNA, INC.	-6.41x	8.8x	-5.38x	-.--%	21.98B
INCYTE CORPORATION	15.2x	2.66x	8.22x	-.--%	19.93B
INNOVENT BIOLOGICS, INC.	49.02x	5.22x	37.44x	-.--%	16.95B
SWEDISH ORPHAN BIOVITRUM AB	24.09x	4.99x	13.47x	-.--%	15.87B
Average	15.67x	5.34x	13.18x	0.56%	33.14B
Weighted average by Cap.	14.69x	5.33x	12.76x	0.7%